These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 11676154

  • 1. [Treatment of steroid-resistant polymyositis and dermatomyositis].
    Mimura T, Kanda H, Kubo K.
    Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154
    [Abstract] [Full Text] [Related]

  • 2. A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis.
    Mira-Avendano IC, Parambil JG, Yadav R, Arrossi V, Xu M, Chapman JT, Culver DA.
    Respir Med; 2013 Jun; 107(6):890-6. PubMed ID: 23517887
    [Abstract] [Full Text] [Related]

  • 3. Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis.
    Tanaka F, Origuchi T, Migita K, Tominaga M, Kawakami A, Kawabe Y, Eguchi K.
    Intern Med; 2000 May; 39(5):428-30. PubMed ID: 10830189
    [Abstract] [Full Text] [Related]

  • 4. Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis.
    Yoshida T, Koga H, Saitoh F, Sakamoto M, Harada M, Yoshida H, Sakisaka S, Sata M.
    Intern Med; 1999 Sep; 38(9):733-8. PubMed ID: 10480306
    [Abstract] [Full Text] [Related]

  • 5. Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis.
    Shimojima Y, Ishii W, Matsuda M, Kishida D, Ikeda SI.
    J Clin Rheumatol; 2017 Mar; 23(2):87-93. PubMed ID: 28225510
    [Abstract] [Full Text] [Related]

  • 6. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine.
    Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, Kita Y, Kawai M, Saito Y, Iwamoto I.
    J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic advances in myositis.
    Aggarwal R, Oddis CV.
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [Abstract] [Full Text] [Related]

  • 8. [Polymyositis: disease course and therapy with intravenously administered immunoglobulins].
    Stoll T, Michel BA, Neidhart M, Wassmer P, Neidl K, Fehr K, Wagenhäuser FJ.
    Schweiz Med Wochenschr; 1992 Sep 26; 122(39):1458-65. PubMed ID: 1411405
    [Abstract] [Full Text] [Related]

  • 9. Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis.
    Suzuki Y, Hayakawa H, Miwa S, Shirai M, Fujii M, Gemma H, Suda T, Chida K.
    Lung; 2009 Sep 26; 187(3):201-6. PubMed ID: 19387736
    [Abstract] [Full Text] [Related]

  • 10. [New therapeutic approaches for polymyositis and dermatomyositis].
    Dankó K, Vincze M.
    Orv Hetil; 2011 Sep 25; 152(39):1552-9. PubMed ID: 21920841
    [Abstract] [Full Text] [Related]

  • 11. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis.
    Yamasaki Y, Yamada H, Yamasaki M, Ohkubo M, Azuma K, Matsuoka S, Kurihara Y, Osada H, Satoh M, Ozaki S.
    Rheumatology (Oxford); 2007 Jan 25; 46(1):124-30. PubMed ID: 16754626
    [Abstract] [Full Text] [Related]

  • 12. [Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy].
    Takeda Y, Tomino Y.
    Nihon Rinsho; 2004 Oct 25; 62(10):1875-9. PubMed ID: 15500133
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis.
    Kurita T, Yasuda S, Amengual O, Atsumi T.
    Lupus; 2015 Jan 25; 24(1):3-9. PubMed ID: 25297551
    [Abstract] [Full Text] [Related]

  • 14. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment.
    Schnabel A, Reuter M, Biederer J, Richter C, Gross WL.
    Semin Arthritis Rheum; 2003 Apr 25; 32(5):273-84. PubMed ID: 12701038
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura.
    Ogimi C, Honma N, Tanaka R, Oh-ishi T.
    Mod Rheumatol; 2012 Apr 25; 22(2):280-3. PubMed ID: 21710356
    [Abstract] [Full Text] [Related]

  • 16. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?
    Maeda K, Kimura R, Komuta K, Igarashi T.
    Scand J Rheumatol; 1997 Apr 25; 26(1):24-9. PubMed ID: 9057798
    [Abstract] [Full Text] [Related]

  • 17. [Successful combination chemotherapy with low-dose methotrexate and steroids for dermatomyositis complicated by interstitial pneumonitis].
    Itoh T, Mitsuoka S, Uji M, Matsushita H.
    Nihon Kokyuki Gakkai Zasshi; 1999 Aug 25; 37(8):636-40. PubMed ID: 10496104
    [Abstract] [Full Text] [Related]

  • 18. Interstitial lung disease due to polymyositis or dermatomyositis: effect of a 6-month course of i.v. pulse cyclophosphamide.
    Meyer O, Hayem G, Palazzo E, Crestani B, Debray MP, Ballard M.
    Clin Exp Rheumatol; 2005 Aug 25; 23(5):724. PubMed ID: 16173257
    [No Abstract] [Full Text] [Related]

  • 19. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH, Hoogendijk JE, Lecky B, Winer JB, Gordon P.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD003643. PubMed ID: 19821312
    [Abstract] [Full Text] [Related]

  • 20. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH, Hoogendijk JE, Lecky B, Winer JB.
    Cochrane Database Syst Rev; 2005 Jul 20; (3):CD003643. PubMed ID: 16034905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.